rs771820315
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_000359.3(TGM1):c.967C>T(p.Arg323Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,459,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R323Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000359.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM1 | NM_000359.3 | c.967C>T | p.Arg323Trp | missense_variant | 6/15 | ENST00000206765.11 | NP_000350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.967C>T | p.Arg323Trp | missense_variant | 6/15 | 1 | NM_000359.3 | ENSP00000206765.6 | ||
TGM1 | ENST00000559136.1 | c.40C>T | p.Arg14Trp | missense_variant | 2/7 | 5 | ENSP00000453337.1 | |||
TGM1 | ENST00000544573.5 | c.-28-1333C>T | intron_variant | 2 | ENSP00000439446.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000163 AC: 4AN: 245428Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133122
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1459034Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 725620
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Autosomal recessive congenital ichthyosis 1 Pathogenic:3Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 04, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 25, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | Mar 22, 2022 | Same nucleotide change resulting in same amino acid change has been previously reported to be associated with TGM1 related disorder (PMID:19241467). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000012484, PMID:7824952,32573669). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.898>=0.6, 3CNET: 0.998>=0.75). A missense variant is a common mechanism . It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency:0.0000163). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 05, 2023 | This variant disrupts the p.Arg323 amino acid residue in TGM1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7824952, 9261103, 9545389, 23278109). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGM1 protein function. ClinVar contains an entry for this variant (Variation ID: 449108). This missense change has been observed in individuals with autosomal recessive congenital ichthyosis (PMID: 19241467, 31168818, 31953843). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 323 of the TGM1 protein (p.Arg323Trp). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 06, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31168818, 31953843, 19241467, 23278109) - |
Lamellar ichthyosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 30, 2022 | Variant summary: TGM1 c.967C>T (p.Arg323Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 245428 control chromosomes (gnomAD). c.967C>T has been reported in the literature in individuals affected with Ichthyosis, including at least two cases where it has been found in trans with a pathogenic variant and one homozygous case (e.g. Herman_2009, Simpson_2020, Cheng_2020). These data indicate that the variant is likely to be associated with disease. This variant results in an amino acid change at the same position as another variant, c.968G>A (p.Arg323Gln), that has been classified as pathogenic with strong supporting evidence (ClinVar: 12484), suggesting this site may be important for normal protein function. To our knowledge, this has yet to be investigated by functional studies. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Two laboratories classified the variant as likely pathogenic, one as pathogenic, and one classified it as VUS. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at